相似文献
1
Cervical cancer: the Chilean perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S235-8. doi: 10.1016/S0020-7292(06)60038-6.
2
Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10. doi: 10.1016/S0020-7292(06)60035-0.
3
Cervical cancer: the South African perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S211-4. doi: 10.1016/S0020-7292(06)60036-2.
4
Cervical cancer: the Indian perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S215-33. doi: 10.1016/S0020-7292(06)60037-4.
5
Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
J Womens Health (Larchmt). 2008 Jan-Feb;17(1):5-10. doi: 10.1089/jwh.2007.0705.
6
Development of a public health research program for ovarian cancer.
J Womens Health (Larchmt). 2006 May;15(4):339-45. doi: 10.1089/jwh.2006.15.339.
7
The future of the Pap: where is cervical cancer screening headed?
Nurs Womens Health. 2008 Oct;12(5):427-31. doi: 10.1111/j.1751-486X.2007.00367.x.
8
New Pap test guidelines recommend less frequent screening for most women.
Mayo Clin Womens Healthsource. 2010 May;14(5):3.
9
[Central Coordinating Center. Summary of Cervical Cancer Population Screening Program in the period from January the 1st 2007 till September 30th 2007].
Ginekol Pol. 2007 Dec;78(12):998-1001.
10
引用本文的文献
1
Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
BMC Public Health. 2014 Nov 26;14:1222. doi: 10.1186/1471-2458-14-1222.
Zotero 插件